Covid test maker Novacyt saw sales rise 20-fold last year
Covid test maker Novacyt saw sales rise 20-fold during the pandemic prompting its share price to rise 5,000% in a year Annual profits expected to jump from £1.6m to £91.8m in fresh results AIM-listed group’s share price has rocketed, but closed down 17% on Friday By City & Finance Reporter for the Daily Mail and … Read more